DermTech Operating Margin from 2010 to 2024
| DMTK Stock | USD 0.60 0.01 1.69% |
Check DermTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DermTech main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 1.6 M or Selling General Administrative of 46 M, as well as many exotic indicators such as Price To Sales Ratio of 3.55, Dividend Yield of 0.0 or PTB Ratio of 0.95. DermTech financial statements analysis is a perfect complement when working with DermTech Valuation or Volatility modules.
DermTech | Operating Margin |
Latest DermTech's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of DermTech over the last few years. It is DermTech's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DermTech's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (5.03) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
DermTech Operating Margin Regression Statistics
| Arithmetic Mean | (5.79) | |
| Coefficient Of Variation | (15.96) | |
| Mean Deviation | 0.75 | |
| Median | (5.23) | |
| Standard Deviation | 0.92 | |
| Sample Variance | 0.86 | |
| Range | 2.9059 | |
| R-Value | (0.77) | |
| Mean Square Error | 0.38 | |
| R-Squared | 0.59 | |
| Significance | 0.0008 | |
| Slope | (0.16) | |
| Total Sum of Squares | 11.97 |
DermTech Operating Margin History
About DermTech Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include DermTech income statement, its balance sheet, and the statement of cash flows. DermTech investors use historical funamental indicators, such as DermTech's Operating Margin, to determine how well the company is positioned to perform in the future. Although DermTech investors may use each financial statement separately, they are all related. The changes in DermTech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on DermTech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on DermTech Financial Statements. Understanding these patterns can help to make the right decision on long term investment in DermTech. Please read more on our technical analysis and fundamental analysis pages.
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. The company sells its products primarily to pathology and oncology practitioners. Dermtech operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 255 people.
Pair Trading with DermTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DermTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DermTech will appreciate offsetting losses from the drop in the long position's value.Moving together with DermTech Stock
| 0.69 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
Moving against DermTech Stock
| 0.8 | HCM | HUTCHMED DRC | PairCorr |
| 0.65 | FLGC | Flora Growth Corp Financial Report 20th of May 2024 | PairCorr |
| 0.57 | CGC | Canopy Growth Corp Downward Rally | PairCorr |
| 0.54 | BHC | Bausch Health Companies Financial Report 2nd of May 2024 | PairCorr |
| 0.53 | ACB | Aurora Cannabis Downward Rally | PairCorr |
The ability to find closely correlated positions to DermTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DermTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DermTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DermTech to buy it.
The correlation of DermTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DermTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DermTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DermTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of DermTech Correlation against competitors. For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for DermTech Stock analysis
When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 0.469 | Quarterly Revenue Growth 0.311 | Return On Assets (0.38) | Return On Equity (1.06) |
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.